OBiO Technology Partners with Shenzhen Innovation Immunotechnology for TCR-T Cell Therapy Development
OBiO Technology (Shanghai) Co., Ltd (SHA: 688238), a leading Contract Research Organization (CRO) specializing in...
Deals
BOE-Backed Genewise Bio Secures RMB 100 Million in Series A Financing for Molecular Diagnostics
Genewise Bio, a molecular diagnostics company nurtured by BOE Technology Group, has reportedly secured RMB...
Zhaoke Ophthalmology Partners with China’s Eye Valley to Establish Ophthalmic Research Institute
Lee’s Pharmaceutical Holdings Ltd (HKG: 0950), a China-based pharmaceutical company, has announced that its subsidiary,...
Eli Lilly Acquires QurAlis’ UNC13A-Targeting Compounds for Neurodegenerative Diseases
Eli Lilly and Company (NYSE: LLY) has announced the acquisition of global development and commercialization...
Akeso Expands Licensing Deal with Summit Therapeutics for Ivonescimab Bispecific Antibody
Akeso Inc. (HKG: 9926), a biopharmaceutical company based in China, has announced a supplementary licensing...
Changchun GeneScience to Distribute TWi Pharma’s Megestrol in China and Southeast Asia
Changchun GeneScience Pharmaceutical Co., Ltd, a biopharmaceutical company based in China, has entered into an...
MSD to Acquire Ophthalmology Specialist Eyebiotech in a Deal Valued Up to USD 3 Billion
Merck, Sharp & Dohme (MSD; NYSE: MRK) has entered into an agreement to acquire UK-based...
TÜV Partners with Lancy Co., Ltd’s BRAVOU to Enhance Medical Aesthetics Services in China
Technischer Überwachungs-Verein (TÜV), a Germany-based international independent third-party testing, inspection, and certification organization, has entered...
Burning Rock Expands Companion Diagnostics Partnership with Bayer for Precision Oncology in China
Burning Rock Ltd (NASDAQ: BNR), a China-based medical technology company, has announced another partnership in...
Parexel Partners with Ruijin Hospital Hainan Subsidiary to Enhance Real-World Evidence in Drug Development
Parexel, a U.S.-based contract research organization (CRO), has entered into a partnership with Shanghai Ruijin...
Lucy Therapeutics Boosts CNS Disease Research with USD 12.5 Million in Additional Financing
Lucy Therapeutics Inc., a U.S.-based developer of small-molecule drugs for central nervous system (CNS) diseases,...
Johnson & Johnson to Acquire Atopic Dermatitis Therapy NM26 in $1.25 Billion Deal
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare giant, has entered into a definitive...
HuidaGene and Synthego Form Strategic Partnership for CRISPR-Based Therapies
HuidaGene (Shanghai) Biotechnology Co., Ltd, a clinical-stage biotechnology company based in China, has entered into...
Fosun Pharma Rumored to Fully Acquire Subsidiary Henlius Pharmaceutical, Shares Suspended
Rumors are circulating, as reported by Bloomberg citing insiders, that Shanghai Fosun Pharmaceutical (Group) Co.,...
Jiangxi Rimag Group Sets IPO Price Range for Hong Kong Debut, Aims to Raise Up to USD 2.15 per Share
Jiangxi Rimag Group Co., Ltd, a leading medical imaging services provider based in China, has...
IVD Medical Holding Ltd Enters Non-Binding MoU with Chinese Chemiluminescence IVD Company for Potential Collaboration
IVD Medical Holding Ltd (HKG: 1931), a leading in vitro diagnostic (IVD) company based in...
BMS Strikes Deal with Prothena for Potential Disease-Modifying Neurology Drug PRX019
Bristol Myers Squibb (BMS; NYSE: BMY) has executed an exclusive global licensing agreement with Prothena...
Gilead Partners with Cartography Biosciences to Develop Therapies for Triple-Negative Breast Cancer
Gilead Sciences (NASDAQ: GILD) has entered into a collaboration agreement with Cartography Biosciences, a US-based...
Sanofi Partners with Bluecrux to Enhance Supply Chain with AI Technologies
Sanofi (NASDAQ: SNY), a leading French pharmaceutical company, is enhancing its supply chain strategy with...
Bio-Thera Solutions Partners with STADA for European Commercialization of Golimumab Biosimilar
Bio-Thera Solutions Ltd (SHA: 688177), a biopharmaceutical company based in China, has announced a licensing...